Abbvie (ABBV) PT Raised to $290 at Cantor Fitzgerald

October 8, 2026 7:10 AM EDT Send to a Friend
Cantor Fitzgerald analyst Carter Gould raised the price target on Abbvie (NYSE: ABBV) to $290.00 (from $285.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login